Assistant Professor
Center for Vaccine Development, University of Maryland Medical Center
Baltimore, MD, United States
Dr. Meagan Deming is a board-certified Infectious Disease specialist with a primary research interest in respiratory viruses, including coronaviruses and influenza. She earned her MD & PhD at the University of North Carolina studying SARS-coronavirus vaccine strategies and antibody neutralization. She has served as a covering physician for COVID-19 vaccine and therapeutic clinical trials, including helping to lead the ‘Mix and Match’ trial studying delayed heterologous SARS-CoV-2 vaccines. Currently an assistant professor at the University of Maryland Center for Vaccine Development and Global Health, she is an active investigator in the CIVICs network, working on an influenza challenge study as well as influenza vaccine clinical trials, and is PI for the 'SNIFF study' exploring asymptomatic SARS-CoV-2 infections after vaccination.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
81 - Late Breaking Vaccine Studies
Thursday, October 20, 2022
1:45 PM - 3:00 PM US ET
212 - Toward a Universal SARS-CoV-2 Vaccine
Saturday, October 22, 2022
10:30 AM - 11:45 AM US ET
1643 - Coronavirus Challenge Models
Saturday, October 22, 2022
10:30 AM - 10:55 AM US ET
271 - What’s New in Respiratory Viruses
Saturday, October 22, 2022
3:15 PM - 4:30 PM US ET